Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on August 10, 2026

Aug. 10, 2026

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

Indeterminate GlobeNewswire

Aug. 10, 2026

Wave Life Sciences Announces Completion of Redomiciliation to Delaware

Indeterminate GlobeNewswire

Aug. 10, 2026

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

Indeterminate GlobeNewswire

Aug. 10, 2026

Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award

Indeterminate GlobeNewswire

Aug. 10, 2026

Vystar Completes Acquisition of R3ALM Financial Ecosystem, Targets $120 Million Tokenized Equity Launch 

Indeterminate GlobeNewswire

Aug. 10, 2026

Lingerie Fighting Championships and Shine Wrestling Join Forces for Historic Double-Header Event in Clearwater, Florida

Indeterminate GlobeNewswire

Aug. 10, 2026

Silo Pharma Granted European Patent Covering Novel PTSD Therapy

Indeterminate GlobeNewswire

Aug. 10, 2026

Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO

Indeterminate GlobeNewswire

Aug. 10, 2026

Flash (Nasdaq: FLZH) Completes LPL Season 6, Streamed to North America on Its Own OTT Platform flashsm.com

Indeterminate GlobeNewswire

Aug. 10, 2026

Alvotech to Report Financial Results for H1 2026

Indeterminate GlobeNewswire

Aug. 10, 2026

Life Biosciences Appoints Stephen Webster to Board of Directors

Indeterminate GlobeNewswire

Aug. 10, 2026

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 10, 2026

Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models

Indeterminate GlobeNewswire

Aug. 10, 2026

Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Aug. 10, 2026

Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D

Indeterminate GlobeNewswire

Aug. 10, 2026

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Indeterminate GlobeNewswire

Aug. 10, 2026

Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa

Indeterminate GlobeNewswire

Aug. 10, 2026

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 10, 2026

Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market

Indeterminate GlobeNewswire

Aug. 10, 2026

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

Indeterminate GlobeNewswire